ctrl K

Price Alert

Fortrea Inc. (FTRE)

NASDAQ: FTRE · Real-Time Price · USD

8.92

-0.55 (-5.81%)

At close: Sep 25, 2025, 3:59 PM

8.92

0.00%

After-hours: Sep 25, 2025, 04:55 PM EDT

Fortrea Revenue Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Clinical Services Segment Revenue	710.3M	651.3M	1.4B	711.7M	726.1M
Clinical Services Segment Revenue Growth	+9.06%	-53.53%	+96.95%	-1.98%	n/a

Revenue by Geography

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Europe Revenue	218.7M	200.3M	399.9M	191.8M	195.9M	208.3M	422.8M	204.3M	200.4M
Europe Revenue Growth	+9.19%	-49.91%	+108.50%	-2.09%	-5.95%	-50.73%	+106.95%	+1.95%	n/a
North America Revenue	344.3M	309.5M	643.9M	319.7M	317.9M	305.9M	813.9M	411.8M	437.8M
North America Revenue Growth	+11.24%	-51.93%	+101.41%	+0.57%	+3.92%	-62.42%	+97.64%	-5.94%	n/a
Other Geographical Areas Revenue	147.3M	141.5M	315.6M	163.4M	148.6M	147.9M	302.9M	160.3M	154.8M
Other Geographical Areas Revenue Growth	+4.10%	-55.16%	+93.15%	+9.96%	+0.47%	-51.17%	+88.96%	+3.55%	n/a

Operating Expense Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
Selling, General, and Administrative Revenue	124.8M	121.8M	148.1M	136.3M	156.2M	120.1M	98.9M	106.8M	80.8M	79.6M	83.4M	70.7M	71.2M	75M
Selling, General, and Administrative Revenue Growth	+2.46%	-17.76%	+8.66%	-12.74%	+30.06%	+21.44%	-7.40%	+32.18%	+1.51%	-4.56%	+17.96%	-0.70%	-5.07%	n/a
Research and Development Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Research and Development Revenue Growth	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a

Ask AI